Ivan Tornos on robotics
From When You Are the Boldest... · · Mullings Group
“Monogram Technologies will be the first technology company in orthopedic robotics that enables fully autonomous procedures. I'm not here to tell you that Zimmer Biomet wants to eliminate the surgeon — I'm here to tell you we will provide optionality, from the surgeon fully in charge to, in some rural areas like India, the robot doing the surgery by itself.”
On , Ivan Tornos, President, CEO & Chairman of the Board at Zimmer Biomet Holdings Inc, spoke about robotics during When You Are the Boldest... on Mullings Group.
About Ivan Tornos
Ivan Tornos, President, CEO and Chairman of Zimmer Biomet, has described the company as undergoing a transformation from a legacy product company to a technology company. In public appearances throughout 2025, Tornos stated that the company is disrupting its strategy, operations, and culture while keeping its purpose of alleviating pain unchanged. He highlighted the company’s focus on autonomous robotics, smart implants, data algorithms, and remote surgery capabilities, including a partnership with Monogram Technologies for fully autonomous procedures and a collaboration with Microsoft for mixed-reality guided surgeries. Tornos also noted that Zimmer Biomet plans to launch 50 new products over 36 months and that 40 to 60 percent of orthopedic cases are expected to shift to ambulatory surgical centers. Tornos has emphasized the importance of patient awareness, citing that 600 million people suffer from arthritis but fewer than 5 percent seek treatment. He discussed a partnership with Arnold Schwarzenegger, who serves as Chief Wellness Officer, to educate patients about